|
1CXZ
CRYSTAL STRUCTURE OF HUMAN RHOA COMPLEXED WITH THE EFFECTOR DOMAIN OF THE PROTEIN KINASE PKN/PRK1
Deposited 1999-08-31
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
13–98(86 aa)
Fragment:RESIDUES 13 - 98
|
Not recorded
|
MG MAGNESIUM ION × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH;pH 6.5;277 K;PEG 300, pH 6.5, MICROBATCH, temperature 277K
|
Resolution 2.20 Å
R-free 0.268
|
|
1URF
HR1b domain from PRK1
Deposited 2003-10-29
|
Different construct
Different experimental conditions
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
122–199(78 aa)
Fragment:HR1B, RESIDUES 122-199
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 60;Pressure 1
|
Resolution not provided
|
|
2RMK
Rac1/PRK1 Complex
Deposited 2007-10-25
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
122–199(78 aa)
Fragment:HR1b domain, REM 2, UNP residues 122-199
|
Not recorded
|
MG MAGNESIUM ION × 1
GCP PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER × 1
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 0.225;Pressure ambient
NMR sample composition
0.6mM [U-13C; U-15N; U-2H] Rac1; 0.6mM PRK1 HR1b; 0.7mM PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6mM [U-100% 13C; U-100% 15N] Rac1; 0.6mM PRK1 HR1b; 0.7mM PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6mM [U-100% 15N] Rac1; 0.6mM PRK1 HR1b; 0.7mM PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6mM [U-100% 13C; U-100% 15N] Rac1; 0.6mM PRK1 Rac1; 0.7mM PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER; 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
0.6mM [U-100% 15N] HR1b; 0.6mM PRK1 Rac1; 0.7mM PHOSPHOMETHYLPHOSPHONIC ACID GUANYLATE ESTER; 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
4NKG
Crystal structure of SspH1 LRR domain in complex PKN1 HR1b domain
Deposited 2013-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
122–199(78 aa)
Fragment:HR1b domain, REM 2 domain, UNP residues 122-199
|
Not recorded
|
HEZ HEXANE-1,6-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;26% PEG3350, 0.18M tri-Ammonium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.90 Å
R-free 0.242
|
|
4NKG
Crystal structure of SspH1 LRR domain in complex PKN1 HR1b domain
Deposited 2013-11-12
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
122–199(78 aa)
Fragment:HR1b domain, REM 2 domain, UNP residues 122-199
|
Not recorded
|
HEZ HEXANE-1,6-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;26% PEG3350, 0.18M tri-Ammonium citrate, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.90 Å
R-free 0.242
|
|
4OTD
Crystal Structure of PRK1 Catalytic Domain
Deposited 2014-02-13
|
Different construct
Different mutation/modification
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
605–942(338 aa)
Fragment:UNP residues 605-942
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion
|
Resolution 2.00 Å
R-free 0.221
|
|
4OTG
Crystal Structure of PRK1 Catalytic Domain in Complex with Lestaurtinib
Deposited 2014-02-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
605–942(338 aa)
Fragment:UNP residues 605-942
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
2V9 Lestaurtinib × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion
|
Resolution 2.60 Å
R-free 0.268
|
|
4OTH
Crystal Structure of PRK1 Catalytic Domain in Complex with Ro-31-8220
Deposited 2014-02-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
605–942(338 aa)
Fragment:UNP residues 605-942
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
DRN BISINDOLYLMALEIMIDE IX × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion
|
Resolution 1.80 Å
R-free 0.266
|
|
4OTI
Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib
Deposited 2014-02-13
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
605–942(338 aa)
Fragment:UNP residues 605-942
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MI1 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8.5;100mM Tris pH 8.5, 150-225mM Ammonium acetate, 23-28% PEG 3350, Vapor diffusion
|
Resolution 1.93 Å
R-free 0.226
|